Literature DB >> 7074045

Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier.

W X Tian, C L Tsou.   

Abstract

On the basis of the equations derived previously [Tsou, C. L. (1965) Sheng Wu Hua Hsueh Yu Sheng Wu Wu Li Hsueh Pao 5, 398-408, 409-417] for the substrate reaction during the course of enzyme modification, the kinetic behavior of the system chymotrypsin-substrate-modifier has been studied. The kinetics of benzoyltyrosine ester hydrolysis during the course of irreversible inhibition of the enzyme has been found to be in satisfactory agreement with equations obtained previously. The apparent rate constant between the enzyme and an irreversible inhibitor can be easily obtained in one single experiment by following the course of substrate hydrolysis in the presence of the inhibitor. The results are also in accord with the assumption that diisopropyl fluorophosphate can be classified as an irreversible competitive inhibitor. For both phenylmethanesulfonyl fluoride and L-1-[(p-toluene-sulfonyl)amino]-2-phenylethyl chloromethyl ketone, the inhibition has been found to be in agreement with the kinetics of the complexing type; i.e., a noncovalent enzyme-inhibitor complex is formed before irreversible enzyme modification. Both the equilibrium constants for the complex formation and the first-order rate constants for the irreversible modification step have been determined also by following the course of substrate hydrolysis in the presence of the irreversible inhibitor.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7074045     DOI: 10.1021/bi00534a031

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  70 in total

1.  Influence of substrates on in vitro dephosphorylation of glycogen phosphorylase a by protein phosphatase-1.

Authors:  Z X Wang
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

2.  Peptidyl inverse esters of p-methoxybenzoic acid: a novel class of potent inactivator of the serine proteases.

Authors:  J Lynas; B Walker
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

3.  Kinetic differentiation between enzyme inactivation involving complex-formation with the inactivator and that involving a conformation-change step.

Authors:  C Liu; C L Tsou
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

4.  The effects of systematic errors on the analysis of irreversible enzyme inhibition progress curves.

Authors:  P Gray
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

5.  The synthesis, kinetic characterization and application of a novel biotinylated affinity label for cathepsin B.

Authors:  B Walker; B M Cullen; G Kay; I M Halliday; A McGinty; J Nelson
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

6.  The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif.

Authors:  Kailash C Pandey; Stephanie X Wang; Puran S Sijwali; Anthony L Lau; James H McKerrow; Philip J Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-17       Impact factor: 11.205

7.  Novel non-peptidic vinylsulfones targeting the S2 and S3 subsites of parasite cysteine proteases.

Authors:  Clifford Bryant; Iain D Kerr; Moumita Debnath; Kenny K H Ang; Joseline Ratnam; Rafaela S Ferreira; Priyadarshini Jaishankar; DongMei Zhao; Michelle R Arkin; James H McKerrow; Linda S Brinen; Adam R Renslo
Journal:  Bioorg Med Chem Lett       Date:  2009-09-03       Impact factor: 2.823

8.  Discovery of covalent enzyme inhibitors using virtual docking of covalent fragments.

Authors:  Sandipan Roy Chowdhury; Steven Kennedy; Kai Zhu; Rama Mishra; Patrick Chuong; Alyssa-Uyen Nguyen; Stefan G Kathman; Alexander V Statsyuk
Journal:  Bioorg Med Chem Lett       Date:  2018-11-09       Impact factor: 2.823

9.  Human liver cathepsin L.

Authors:  R W Mason; G D Green; A J Barrett
Journal:  Biochem J       Date:  1985-02-15       Impact factor: 3.857

10.  Sucrose octasulfate selectively accelerates thrombin inactivation by heparin cofactor II.

Authors:  Suryakala Sarilla; Sally Y Habib; Dmitri V Kravtsov; Anton Matafonov; David Gailani; Ingrid M Verhamme
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.